NCT05428462

Brief Summary

Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 23, 2022

Completed
Last Updated

July 5, 2022

Status Verified

May 1, 2022

Enrollment Period

Same day

First QC Date

June 16, 2022

Last Update Submit

June 29, 2022

Conditions

Keywords

Psychoeducation dayinternalized stigmatization

Outcome Measures

Primary Outcomes (2)

  • Comparison of internalized stigma of mental illnessillness

    Comparison of internalized stigma of mental illness between pre-treatment

    At immediate post-intervention

  • Comparison of internalized stigma of mentalillness

    Comparison of internalized stigma of mental illness between pre-treatment

    At 3 months post-intervention

Secondary Outcomes (20)

  • Depressive symptoms using the Beck Depression Inventory

    At immediate post-intervention

  • Depressive symptoms using the Beck Depression Inventory

    At 3 months post-intervention

  • Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)

    At immediate post-intervention

  • Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)

    At 3 months post-intervention

  • Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)

    At immediate post-intervention

  • +15 more secondary outcomes

Interventions

Transmission of latest knowledge on borderline personality disorder

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is patients with Borderline Personality disorder assesed according to the SCID II

You may qualify if:

  • Patients with Borderline Personality disorder assessed according to SCID II
  • Having attended the borderline education day

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Montpellier, 34000, France

Location

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2022

First Posted

June 23, 2022

Study Start

January 1, 2021

Primary Completion

January 1, 2021

Study Completion

September 1, 2021

Last Updated

July 5, 2022

Record last verified: 2022-05

Locations